Prasugrel Hydrochloride Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Global Prasugrel Hydrochloride Market
Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine. Similar to clopidogrel, prasugrel is a prodrug that requires enzymatic transformation in the liver to its active metabolite, R-138727. R-138727 irreversibly binds to P2Y12 type ADP receptors on platelets thus preventing activation of the GPIIb/IIIa receptor complex. As a result, inhibition of ADP-mediated platelet activation and aggregation occurs. Prasugrel was developed by Daiichi Sankyo Co. and is currently marketed in the United States and Canada in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). FDA approved in 2009.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-9O8387/Global_Prasugrel_Hydrochloride_Market_Insights_Forecast_to_2028

The global Prasugrel Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Prasugrel Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Prasugrel Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Prasugrel Hydrochloride include Daiichi Sankyo, Amneal Pharmaceuticals, Apotex, Ube, Ascend Laboratories, Liberty Pharmaceuticals and Panacea Biotec, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prasugrel Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prasugrel Hydrochloride.
The Prasugrel Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prasugrel Hydrochloride market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prasugrel Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-9O8387/Global_Prasugrel_Hydrochloride_Market_Insights_Forecast_to_2028

Key Segmentations
By Company
• Daiichi Sankyo
• Amneal Pharmaceuticals
• Apotex
• Ube
• Ascend Laboratories
• Liberty Pharmaceuticals
• Panacea Biotec
Segment by Type
• 5mg
• 10mg
Segment by Application
• Hospital
• Drugs Store

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-9O8387/global-prasugrel-hydrochloride

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.